← Leaderboards
Brian R. Davis
University Of Texas Hlth Sci Ctr Houston
$2,799,415
Attributed
$5,188,580
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,416,080 · 4
By mechanism
R01$3,783,695 · 1
P30$2,227,500 · 1
RC1$994,635 · 1
R21$410,250 · 1
Top collaborators
- Eric J Sorscher5 shared
- Rick A. Wetsel1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Joseph L Alcorn$3,846,955
- Melinda A Stanley$6,213,401
- Charles S Cleeland$9,898,596
- Theresa J Ochoa$2,833,958
- Thomas George Cleary$960,485
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationIn VivoCellsCystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisResearch PriorityLaboratoriesRespiratoryResponseInnovationSamplingCystic Fibrosis PatientsPathogenesisProteinsCell LineStructureCell ModelBiological ModelsEvaluationDrug DiscoveryExhibitsGenotypeIn VitroGenes
Grant awards (10)
UAB CF Research and Translation Core Center$1,113,750
P30 · FY2025 · DK · contact PI
UAB CF Research and Translation Core Center$1,113,750
P30 · FY2024 · DK · contact PI
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine$736,241
R01 · FY2022 · HL
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine$745,791
R01 · FY2021 · HL
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine$757,115
R01 · FY2020 · HL
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine$758,201
R01 · FY2019 · HL
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine$786,347
R01 · FY2018 · HL
Gene corrected iPS-derived lung cells for therapy of inherited lung diseases$994,635
RC1 · FY2010 · HL · contact PI
Somatic Mosaicism in the Wiskott-Aldrich Syndrome$222,750
R21 · FY2010 · AI · contact PI
Somatic Mosaicism in the Wiskott-Aldrich Syndrome$187,500
R21 · FY2009 · AI · contact PI